Epilepsy care in Indigenous and remote communities must be understood locally, not through a single global stereotype. Indigenous peoples are culturally, historically and politically diverse, and the barriers faced by a remote community in Australia may differ substantially from those affecting Māori, First Nations, Inuit, Native American or other Indigenous populations.
Why this needs its own epilepsy page
Geographic isolation can combine with structural inequity, workforce shortages, transport barriers, medication delays and culturally unsafe healthcare.
These factors can affect diagnosis, seizure control and access to specialist treatment.
What the 2025 evidence shows
A systematic scoping review published in The Lancet Global Health examined epilepsy among Indigenous peoples in Canada, Australia, New Zealand and the United States.
Across the available evidence, recurring themes included reduced specialist access, longer waits or reduced access to antiseizure medicines, higher hospital use and important mortality and disability inequities in some populations.
The evidence itself is incomplete
The same review found relatively few studies and substantial variation in study quality.
This means apparent differences in epilepsy prevalence or outcomes should not be assumed to apply to every Indigenous population.
Distance from specialist care
Remote communities may be hundreds of kilometres from EEG, MRI, paediatric neurology, epilepsy surgery or emergency services.
Travel can require time away from family, work and community and may depend on weather, roads or air transport.
Medication continuity
Delayed dispensing, stock shortages, transport disruption and limited pharmacy access can make consistent antiseizure treatment more difficult.
Interruptions are especially dangerous for people at risk of seizure clusters or status epilepticus.
Culturally safe care
Clinical effectiveness depends on trust.
Care designed without community input may conflict with language needs, cultural beliefs, family structures or previous experiences of discrimination and colonial health systems.
Culturally safe epilepsy care therefore requires partnership rather than simply translating existing services.
Community leadership
Health programmes should involve local communities, Indigenous health workers and community-controlled services wherever possible.
A 2026 Australian systematic review of remote primary care similarly emphasised that healthcare models should respond to community-identified needs and local cultural governance.
Traditional knowledge and biomedical treatment
Traditional explanations of illness and biomedical models may coexist.
Respectful care does not require clinicians to present unproven treatments as effective, but it does require understanding the person’s beliefs and working collaboratively where practices are safe.
Tele-neurology
Remote video consultation can reduce some travel burden and improve specialist access.
It cannot solve every gap: reliable internet, local examination, EEG, imaging, medication supply and emergency response still require physical infrastructure.
Emergency planning
Where emergency services are distant, seizure action plans, rescue-medication access and training for family or local health workers can be particularly important.
Data sovereignty and research
Indigenous communities have repeatedly raised concerns about research conducted without adequate governance, benefit or community control.
Epilepsy surveillance and research should respect Indigenous data-governance principles and avoid treating very different peoples as one category.
WHO global action
The World Health Organization’s Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders 2022–2031 identifies equitable access and priority populations as central to improving neurological care worldwide.
Its implementation toolkit emphasises locally adapted services and involvement of people with neurological conditions, families and communities.
The central point
The major problem is not “Indigenous culture causing poor epilepsy care”. The evidence points instead to structural barriers, unequal specialist access, distance, medication availability and services that do not always reflect community priorities.
Related reading
Global Epilepsy →
The Rural–Urban Epilepsy Treatment Gap →
Access to Antiseizure Medicines Worldwide →
Sources
- Epilepsy in Indigenous peoples in Canada, Australia, New Zealand and the USA — 2025 systematic scoping review
- Primary healthcare access in remote Indigenous Australian communities — 2026 systematic review
- WHO IGAP implementation toolkit — 2024
Evidence checked: September 2026.